Intricon to Announce 2021 Second Quarter Results on Monday, August 9, 2021
Intricon Corporation (NASDAQ: IIN) announced the release of its 2021 second quarter results on August 9, 2021, after market close. A conference call will follow at 4:00 p.m. CT/5:00 p.m. ET, accessible via phone or webcast. Intricon specializes in designing and manufacturing miniature medical devices, emphasizing collaboration throughout the development process. With facilities in the U.S., Asia, and Europe, the company is committed to advancing micro-medical technology for global clients and improving clinical outcomes.
- Upcoming release of Q2 2021 results may provide insights into financial performance.
- Conference call scheduled for August 9 to address investor queries directly.
- None.
ARDEN HILLS, Minn., July 26, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 second quarter results on Monday, August 9, 2021, after market close.
Following the release, Intricon’s management team will host a conference call on the same day, beginning at 4:00 p.m. CT/5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (866) 795-7248 for domestic callers or (470) 495-9160 for international callers, using conference ID: 6328219. A live and archived webcast will be available on the “Investors” sections of the company’s website at: www.intricon.com.
About Intricon Corporation
Intricon is a Joint Development Manufacturer that integrates components and assemblies to advance micro-medical technology across a range of device platforms for global customers. Intricon approaches each engagement with an all-in commitment, working with customers every step of the way- from the earliest idea stages to ongoing production - in order to advance program performance and deliver results. With a focus on key device platforms, Intricon helps advance clinical outcomes by always looking ahead with proactive support and resources through integration of its core competencies. lntricon has facilities in the United States, Asia and Europe. The company's common stock trades under the symbol "IIN" on the NASDAQ Global Market.
Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investorrelations@intricon.com
FAQ
When will Intricon Corporation release its second quarter 2021 results?
What time is the conference call for Intricon's Q2 2021 results?
What is the stock symbol for Intricon Corporation?
How can I access the conference call for Intricon's results?
Where can I find the archived webcast of the conference call?
